Nasdaq:US$14.85 (-0.31) | HKEX:HK$23.20 (-0.30) | AIM:£2.30 (+0)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate